Flic Gabbay

Flic is a respected pharmaceutical physician who has spent 4 decades in drug development. She has held a number of senior positions in big pharma, biotech and CROs in both Europe and North America.

Flic has extensive experience of working on the development, submission and launches of products in infection, respiratory disease, arthritis, immunology, chronic kidney disease and oncology.

A committed entrepreneur, Flic was founding chairman of the steering group that set-up the UK Faculty of Pharmaceutical Medicine (FPM) and currently serves as FPM President.

In 2020, Flic was awarded the fellowship of the Academy of Medical Science and is passionate about bringing pharmaceutical medicine into mainstream medical science and its application to public health.

Flic started her career in big pharma in Rhone Poulenc and Parke Davis, in the latter she held senior positions including global therapeutic head and Board level in UK and Ireland. She started Gabbay Group, a CRO acquired by PPD, was founding chairman of Phico Therapeutics and has been CEO of two small biotech companies. She was also Director of Education at the Drug Safety Research Unit (DSRU) in Southampton and helped set up many courses for training pharmaceutical physicians and others globally.

Flic co-founded tranScrip together with Marcin Mankowski and for several years as tranScrip’s Managing Partner.